Oral Ibrexafungerp for Vulvovaginal Candidiasis Treatment: An Analysis of VANISH 303 and VANISH 306
Author(s) -
Oluwatosin Goje,
Ryan Sobel,
Paul Nyirjesy,
Steven R. Goldstein,
Mark Spitzer,
Brooke Faught,
Shelagh Larson,
Thomas King,
Nkechi Azie,
David Angulo,
Jack D. Sobel
Publication year - 2022
Publication title -
journal of women s health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.195
H-Index - 98
eISSN - 1931-843X
pISSN - 1540-9996
DOI - 10.1089/jwh.2022.0132
Subject(s) - vulvovaginal candidiasis , medicine , dermatology , gynecology , antifungal
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom